Clinical trial

Noctura400 Treatment for Diabetic Retinopathy (CANDLE)

NCT02207712

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2014-11-01

PhaseNA

Study timeline

Study start (actual)2014-11-01Date precision: month

Registry last updated2023-08-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Macular Oedemaunresolved

Interventions

Noctura 400 Eye MaskDEVICE

RanibizumabDRUG · verified · RxNorm: ranibizumab

Sponsors & collaborators

PolyPhotonix Medicallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02207712 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.